Skip to content

EV / EBITDA at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
18.8×+4.2×
Stryker logo
StrykerSYK
22.1×-11.8×
Medtronic logo
MedtronicMDT
13.9×-1.5×
Intuitive Surgical logo
Intuitive SurgicalISRG
77.8×+12.8×

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$17.02B-21.5%
Enterprise value$24.07B-12.7%
P/E22.4×-1.4×
P/S-0.8×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Calculated from Zimmer Biomet Holdings’s reported figures.

Based on the most recent quarter.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's EV / EBITDA?
Zimmer Biomet Holdings (ZBH) reported EV / EBITDA of 10.8× in Q1 2026.
How has Zimmer Biomet Holdings's EV / EBITDA changed year-over-year?
Zimmer Biomet Holdings's EV / EBITDA decreased by 11.3% year-over-year, from 12.2× to 10.8×.
What is the long-term trend for Zimmer Biomet Holdings's EV / EBITDA?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's EV / EBITDA has grown at a -13.0% compound annual growth rate (CAGR), from 79.3× to 45.5×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.